Nuveen’s Fractyl Health GUTS Stock Holding History

Nuveen’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-72,958	Closed	-$86.8K	–	3431
2025 Q1	$86.8K	Hold	72,958	–	–	﹤0.01%	3226
2024 Q4	$150K	Buy	72,958 +27,778	+61%	+$64.7K	﹤0.01%	3252
2024 Q3	$114K	Buy	+45,180	New	+$147K	﹤0.01%	3297

Other funds holding GUTS

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Nuveen's GUTS Position: Q2 2025 in Review

Nuveen sold out of Fractyl Health (GUTS) in Q2 2025, closing a stake of 72,958 shares — an estimated $86.8K sold.

Nuveen first reported a position in GUTS in Q3 2024 and held it in 3 quarters. The position peaked at $150K in Q4 2024. 62 funds tracked by Wall St. Rank hold GUTS as of Q2 2025.

Nuveen reported no remaining Fractyl Health position as of Q2 2025 after selling out during the quarter.
Nuveen sold 72,958 Fractyl Health shares in Q2 2025, an estimated $86.8K.
Nuveen first reported a position in Fractyl Health in Q3 2024 and held it in 3 quarters.
Nuveen's Fractyl Health position peaked at $150K in Q4 2024.
62 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.